Mr. Jonathan E Crane, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1140 W 500 S Ste 9, Vernal, UT 84078 Phone: 435-789-6300 Fax: 435-725-6325 |
Jessica Carr Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1140 W 500 S Ste 9, Vernal, UT 84078 Phone: 435-789-6300 Fax: 435-789-6357 |
Christina Squire Higgins Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1140 W 500 S Ste 9, Vernal, UT 84078 Phone: 435-789-6300 Fax: 435-789-6357 |
Mr. Derek John Schwebach, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2028 W 500 N Ste B, Vernal, UT 84078 Phone: 435-219-6312 |
Tracie Lynn Carmichael, MSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1140 W 500 S Ste 9, Vernal, UT 84078 Phone: 435-789-6300 |
Mckay Esplin, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1880 W 500 N, Vernal, UT 84078 Phone: 435-781-3110 |
Louise Warburton Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 365 W 50 N Ste W8, Vernal, UT 84078 Phone: 435-790-2757 Fax: 435-789-4045 |
Allison Scott Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1140 W 500 S, Vernal, UT 84078 Phone: 435-789-6300 Fax: 435-789-6300 |
Robert D Hall, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1140 W 500 S, Vernal, UT 84078 Phone: 435-789-6300 |
Kirk Heath Mcdougal-deans, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1140 W 500 S Ste 9, Vernal, UT 84078 Phone: 435-789-6300 Fax: 435-725-6325 |
Melinda Allridge Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1140 W 500 S Ste 9, Vernal, UT 84078 Phone: 435-789-6300 Fax: 435-789-6357 |
Diana Lynn Carney Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 365 W 50 N Ste W8, Vernal, UT 84078 Phone: 435-790-2757 |
News Archive
Esperance Pharmaceuticals today announced the completion of the run-in cohort of its Phase 2, randomized, multi‐center trial of EP‑100 in combination with paclitaxel for patients with advanced ovarian cancer. EP‐100 is a targeted membrane‐disrupting peptide (tMDP) designed to seek and destroy cancer cells that overexpress luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.
The old cotton patient gowns and warmed cotton blankets are history in St. Francis' Procedural Services Department. Surgery patients can now control their warmth while wearing the Bair Paws patient adjustable warming system. The Bair Paws system combines forced-air warming and patient gowning in one step.
Halozyme Therapeutics, Inc. today announced Phase 2 results demonstrating that the subcutaneous coinjection of rHuPH20 (recombinant human hyaluronidase, PH20) with lispro significantly improves postprandial hyperglycemia, reduces hypoglycemia, and accelerates the absorption of mealtime insulin in patients with type 2 diabetes.
A new study concludes that widespread screening for cardiovascular risk by measuring blood levels of C-reactive protein (CRP), a protein produced by the liver, should not be advocated.
Mayo Clinic's perspective about how to get high-value health care is the focus of a Perspectives article in the New England Journal of Medicine, published online on Sept. 23, 2009, and in the print issue on Oct. 1, 2009.
› Verified 1 days ago